1. Lymph Vessel Proliferation on Cardiac Biopsy May Help in the Diagnosis of Cardiac Sarcoidosis
- Author
-
Keiko Ohta-Ogo, Teruo Noguchi, Yen‐Hong Kuo, Taka-aki Matsuyama, Yoshihiko Ikeda, Hatsue Ishibashi-Ueda, Toshiyuki Nagai, Yukiko Oe, and Toshihisa Anzai
- Subjects
Male ,Pathology ,medicine.medical_specialty ,Sarcoidosis ,Biopsy ,lymphatic vessel ,H&E stain ,Diagnostic Testing ,030204 cardiovascular system & hematology ,Pathophysiology ,cardiac sarcoidosis ,Masson's trichrome stain ,03 medical and health sciences ,0302 clinical medicine ,Fibrosis ,Idiopathic dilated cardiomyopathy ,medicine ,Lymphatic vessel ,Humans ,Aged ,Cell Proliferation ,Lymphatic Vessels ,Retrospective Studies ,Original Research ,030304 developmental biology ,Heart Failure ,0303 health sciences ,business.industry ,Myocardium ,Inflammatory Heart Disease ,Middle Aged ,medicine.disease ,Lymphatic system ,medicine.anatomical_structure ,Granuloma ,endomyocardial biopsy ,cardiovascular system ,Female ,Lymph ,Cardiomyopathies ,Cardiology and Cardiovascular Medicine ,business ,Follow-Up Studies ,D2‐40 immunostaining - Abstract
Background The diagnosis of cardiac sarcoidosis ( CS ) is challenging because endomyocardial biopsy has only a 20% to 30% sensitivity rate for diagnosis and it presents with similar clinical features of idiopathic dilated cardiomyopathy ( DCM ). Lymphatic vessel proliferation in pulmonary sarcoidosis has been previously demonstrated. In this study, we compared endomyocardial biopsy samples obtained from patients with CS and DCM to determine whether lymph vessel counts using D2‐40 immunostaining can be utilized as a complementary tool to distinguish CS from DCM . Methods and Results Endomyocardial biopsy tissues were obtained from 62 patients with CS (30 patients with a diagnosis made histologically, 32 patients with a diagnosis made clinically), and hematoxylin/eosin, Masson trichrome, and D2‐40 immunostaining were performed. Their results were compared with those from 53 patients with DCM. The histological CS group showed significantly increased lymphatic vessels (12.0 [4.0–40.0] versus 2.6 [1.9–3.4], P P DCM group. The optimal threshold was 7.5 lymphatic vessels, and this resulted in a sensitivity of 0.67 and specificity of 0.96. The clinical CS group diagnosed according to Japanese Circulation Society 2016 criteria showed increased lymphatic vessels (4.0 [3.3–9.0] versus 2.6 [1.9–3.4], P P P P =0.0012) compared with the DCM group. The optimal threshold of lymphatic vessels was 3.5, which resulted in a sensitivity of 0.75 and specificity of 0.68. Conclusions Lymphatic vessel counts using D2‐40 immunostaining may help to distinguish clinical CS without granuloma from DCM .
- Published
- 2019